Case Report
International Journal of Impotence Research (2006) 18, 213–214. doi:10.1038/sj.ijir.3901383; published online 18 August 2005
Epistaxis after PDE-5 inhibitors misuse
G Pomara1, G Morelli1, F Menchini-Fabris1, N Dinelli1, G Campo1, G LiGuori2 and C Selli1
- 1Urology Unit – University of Pisa, S Chiara Hospital, Via Roma, Pisa, Italy
- 2Urology Unit – University of Trieste, Cattinara Hospital, Trieste, Italy
Correspondence: Dr G Pomara, Urology Unit – University of Pisa, S Chiara Hospital, Via Roma, 67, Pisa 56100, Italy. E-mail: g.pomara@libero.it
Received 12 July 2005; Revised 13 July 2005; Accepted 13 July 2005; Published online 18 August 2005.
Abstract
A 32-year-old male presented to our department for recurrent epistaxis during sexual intercourses. The patient controlled the bleeding each time with sponge packs and gauzes. During the consultation, he volunteered that the trigger for the epistaxis appeared to have been misuse of phosphodiesterase (PDE)-5 inhibitors, Viagra and Cialis. This first report of epistaxis after PDE-5 inhibitors in a young patient underline the possibility that in the next years the number of similar cases might increase due to the diffusion of PDE-5 inhibitor misuse in recreational settings.
Keywords:
viagra, cialis, PDE-5 inhibitors, side effects, epistaxis
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy
International Journal of Impotence Research Review
